OBJECTIVE: The aim of the study was to assess the ability of contrast-enhanced computed tomography (CECT) to differentiate aggressive from nonaggressive solid pseudopapillary neoplasms (SPNs). MATERIALS AND METHODS: Forty treatment-naive patients with pathologically proven pancreatic SPNs were included. Imaging characteristics were determined by consensus of 3 radiologists blinded to histopathologic aggressiveness. All patients underwent 4-phase CECT using a pancreatic protocol. The regions of interest of the tumor and the normal pancreas were documented on all phases. Lymph nodes were considered metastatic if greater than 1.0 cm in short-axis diameter.Fisher exact and Wilcoxon rank-sum tests were used to compare between aggressive and nonaggressive tumors. RESULTS: No significant difference was noted between imaging covariates, such as internal hemorrhage, calcification, wall thickness perceptibility, vascular invasion, margins, cystic component, and pancreatic and biliary ductal dilation. Tumors with greater than 62.5 Hounsfield units and progressive enhancement during the delayed phase had aggressive characteristics (P = 0.03). CONCLUSIONS: On delayed phase CECT, pathologically aggressive SPNs may show greater enhancement than nonaggressive SPNs.
OBJECTIVE: The aim of the study was to assess the ability of contrast-enhanced computed tomography (CECT) to differentiate aggressive from nonaggressive solid pseudopapillary neoplasms (SPNs). MATERIALS AND METHODS: Forty treatment-naive patients with pathologically proven pancreatic SPNs were included. Imaging characteristics were determined by consensus of 3 radiologists blinded to histopathologic aggressiveness. All patients underwent 4-phase CECT using a pancreatic protocol. The regions of interest of the tumor and the normal pancreas were documented on all phases. Lymph nodes were considered metastatic if greater than 1.0 cm in short-axis diameter.Fisher exact and Wilcoxon rank-sum tests were used to compare between aggressive and nonaggressive tumors. RESULTS: No significant difference was noted between imaging covariates, such as internal hemorrhage, calcification, wall thickness perceptibility, vascular invasion, margins, cystic component, and pancreatic and biliary ductal dilation. Tumors with greater than 62.5 Hounsfield units and progressive enhancement during the delayed phase had aggressive characteristics (P = 0.03). CONCLUSIONS: On delayed phase CECT, pathologically aggressive SPNs may show greater enhancement than nonaggressive SPNs.
Authors: Susan C Abraham; David S Klimstra; Robb E Wilentz; Charles J Yeo; Kevin Conlon; Murray Brennan; John L Cameron; Tsung-Teh Wu; Ralph H Hruban Journal: Am J Pathol Date: 2002-04 Impact factor: 4.307
Authors: Marcel C C Machado; Marcel Autran C Machado; Telesforo Bacchella; José Jukemura; José L Almeida; José E M Cunha Journal: Surgery Date: 2007-11-05 Impact factor: 3.982
Authors: Chad R Rund; A James Moser; Kenneth K Lee; Herbert J Zeh; Lisa A Teot; Sanja Dacic; Alyssa M Krasinskas Journal: Mod Pathol Date: 2008-02-01 Impact factor: 7.842
Authors: Michael J Wright; Ammar A Javed; Tyler Saunders; Yayun Zhu; Richard A Burkhart; Jun Yu; Jin He; John L Cameron; Martin A Makary; Christopher L Wolfgang; Matthew J Weiss Journal: J Gastrointest Surg Date: 2019-05-09 Impact factor: 3.452
Authors: Jie Yang; Chun-Lu Tan; Dan Long; Yan Liang; Li Zhou; Xu-Bao Liu; Yong-Hua Chen Journal: World J Gastroenterol Date: 2022-09-14 Impact factor: 5.374